Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
Fentanyl Patch Lawsuit MDL to be Considered Next Month June 21, 2012 Austin Kirk Add Your Comments At a hearing next month, a panel of federal judges will consider whether to consolidate and centralize all product liability lawsuits involving problems with fentanyl pain patches manufactured by Watson Pharmaceuticals. According to an order issued last week by the U.S. Judicial Panel on Multidistrict Litigation, oral arguments are scheduled for July 26 in response to a motion filed to consolidate at least 26 fentanyl patch lawsuits brought against the generic drug maker in U.S. District Courts throughout the country. Fentanyl is a painkiller that is about 100 times more powerful than morphine. It is commonly delivered through a patch that is worn on the skin, and is supposed to deliver the medication in a regulated manner through a membrane. Learn More About Fentanyl Patch Lawsuits Learn More SEE IF YOU QUALIFY FOR COMPENSATION Learn More About Fentanyl Patch Lawsuits Learn More SEE IF YOU QUALIFY FOR COMPENSATION All of the clams involve similar allegations that Watson manufactured and sold defective pain patches, which were prone to allowing fentanyl gel to leak directly onto the skin. Given the potency of the opiate painkiller, if the fentanyl gel comes into direct contact with the skin of individuals administering or wearing the pain patch, it can cause a fentanyl overdose, resulting in serious injury and possibly death. Originally introduced as the Duragesic pain patch, manufactured by a subsidiary of Johnson & Johnson, the claims against Watson Pharmaceuticals involve individuals who used the drug maker’s generic version of the fentanyl patch. Since it was developed, the FDA has received hundreds of adverse event reports involving fentanyl overdoses and deaths associated with the use of pain patches, causing many to question whether they can be safely manufactured. According to allegations raised in the Watson fentanyl patch lawsuits, plaintiffs indicate that the problems could have been avoided through the use of a matrix design to hold the fentanyl in the patch, which eliminates the risk of leakage. The complaints allege that Watson knew about the safer alternative design, but instead continued to use a reservoir design, which was prone to leakage, in order to save money. A motion was filed in April, by some of the plaintiffs who have brought lawsuits against Watson, arguing that all claims filed in federal courts throughout the United States involving patches manufactured by the generic drug maker should be consolidated for pretrial proceedings as part of an MDL, or multidistrict litigation. Such consolidation is common in complex product liability claims, where a large number of lawsuits are being pursued involving common facts. Centralizing the cases before one judge reduces duplicative discovery, eliminates contradictory pre-trial rulings from different courts and serves the convenience of the parties, the witnesses and the courts. In a response filed on May 11, Watson agreed that the fentanyl patch litigation should be consolidated as part of an MDL, but argued that lawsuits against other fentanyl patch manufacturers should also be included, identifying additional complaints filed against Mylan and Alza/Sandoz, which manufacture other generic versions of the patch. Mylan has filed an opposition to the suggestion that they be included in any fentanyl patch MDL, arguing that their patch features a dramatically different manufacturing process. Mylan fentanyl pain patches feature the matrix design, as opposed to the reservoir design that Watson pain patches utilize. Therefore, Mylan indicates that the cases have absolutely nothing in common other than the fact that they share the same active pharmaceutical ingredient. Oral arguments will be heard on July 26, at a hearing held at the Carl B. Stokes U.S. Courthouse in Cleveland, Ohio. Tags: Fentanyl, Fentanyl Overdose, Fentanyl Patch, Fentanyl Patch Recall, Overdose, Watson Pharmaceuticals Image Credit: | More Fentanyl Patch Lawsuit Stories U.S. Drug Overdose Deaths Increased 30% to All-Time High in 2020: CDC July 20, 2021 Synthetic Opioid Deaths Increased More Than 1,000% In Recent Years: CDC February 12, 2021 FDA Announces New Risk Mitigation Strategy To Address Opioid Crisis December 28, 2020 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermCommentsThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Oxbryta Settlement Discussions in Class Action Lawsuits Set for Sept. 2025 (Posted: today) A mediator has been appointed to oversee settlement discussions between parties involved in an Oxbryta class action lawsuit, which claims the recalled drug endangered sickle cell disease patients. MORE ABOUT: OXBRYTA LAWSUITWrongful Death Lawsuit Links Oxbryta Side Effects to Deadly Vaso-Occlusive Crises (06/05/2025)Oxbryta Recall Lawsuit Alleges Sickle Cell Drug Increased Frequency of Dangerous VOCs (05/23/2025)First Oxbryta Lawsuit Set for Trial in August 2027, Over Recalled Sickle Cell Drug Risks (05/09/2025) Lawsuit Indicates Biozorb Side Effects Left Woman With Chronic Pain, Disfiguring Injuries (Posted: yesterday) A BioZorb side effects lawsuit indicates that a woman is suffering chronic pain and soreness after the tissue marker implant failed to absorb into her body as advertised. MORE ABOUT: BIOZORB LAWSUITBioZorb Implant Removal Surgery: What Women Need To Know When the Device Fails To Dissolve (06/30/2025)Lawsuit Claims Biozorb Implant Penetrated Skin, Causing Massive Infection (06/04/2025)Breast Cancer Survivors File BioZorb Tissue Marker Lawsuit After Implant Fails (05/20/2025) Second Wave of Valsartan Cancer Lawsuits To Be Ready for Bellwether Trials by January 2026 (Posted: 2 days ago) A new schedule for a second wave of Valsartan cancer lawsuit bellwether trials hopes to have a case ready to go before a jury by January 2026. MORE ABOUT: VALSARTAN LAWSUITCourt Outlines Valsartan Lawsuits Trial Schedule for “Wave 2” Bellwether Cases (05/28/2025)Order Requires Valsartan Recall Lawsuits To Provide Product Identification for Specific Generic Drug Makers Named (03/27/2025)Deadlines Leading to First Valsartan Bellwether Trial on Sept. 8, 2025 Outlined by Special Master (03/04/2025)
Oxbryta Settlement Discussions in Class Action Lawsuits Set for Sept. 2025 (Posted: today) A mediator has been appointed to oversee settlement discussions between parties involved in an Oxbryta class action lawsuit, which claims the recalled drug endangered sickle cell disease patients. MORE ABOUT: OXBRYTA LAWSUITWrongful Death Lawsuit Links Oxbryta Side Effects to Deadly Vaso-Occlusive Crises (06/05/2025)Oxbryta Recall Lawsuit Alleges Sickle Cell Drug Increased Frequency of Dangerous VOCs (05/23/2025)First Oxbryta Lawsuit Set for Trial in August 2027, Over Recalled Sickle Cell Drug Risks (05/09/2025)
Lawsuit Indicates Biozorb Side Effects Left Woman With Chronic Pain, Disfiguring Injuries (Posted: yesterday) A BioZorb side effects lawsuit indicates that a woman is suffering chronic pain and soreness after the tissue marker implant failed to absorb into her body as advertised. MORE ABOUT: BIOZORB LAWSUITBioZorb Implant Removal Surgery: What Women Need To Know When the Device Fails To Dissolve (06/30/2025)Lawsuit Claims Biozorb Implant Penetrated Skin, Causing Massive Infection (06/04/2025)Breast Cancer Survivors File BioZorb Tissue Marker Lawsuit After Implant Fails (05/20/2025)
Second Wave of Valsartan Cancer Lawsuits To Be Ready for Bellwether Trials by January 2026 (Posted: 2 days ago) A new schedule for a second wave of Valsartan cancer lawsuit bellwether trials hopes to have a case ready to go before a jury by January 2026. MORE ABOUT: VALSARTAN LAWSUITCourt Outlines Valsartan Lawsuits Trial Schedule for “Wave 2” Bellwether Cases (05/28/2025)Order Requires Valsartan Recall Lawsuits To Provide Product Identification for Specific Generic Drug Makers Named (03/27/2025)Deadlines Leading to First Valsartan Bellwether Trial on Sept. 8, 2025 Outlined by Special Master (03/04/2025)